 |
PDBsum entry 3mhc
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.4.2.1.1
- carbonic anhydrase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
hydrogencarbonate + H+ = CO2 + H2O
|
 |
 |
 |
 |
 |
hydrogencarbonate
|
+
|
H(+)
|
=
|
CO2
|
+
|
H2O
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Cofactor:
|
 |
Zn(2+)
|
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
|
Bioorg Med Chem Lett
20:4376-4381
(2010)
|
|
PubMed id:
|
|
|
|
|
| |
|
Carbonic anhydrase inhibitors. The X-ray crystal structure of human isoform II in adduct with an adamantyl analogue of acetazolamide resides in a less utilized binding pocket than most hydrophobic inhibitors.
|
|
B.S.Avvaru,
J.M.Wagner,
A.Maresca,
A.Scozzafava,
A.H.Robbins,
C.T.Supuran,
R.McKenna.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
We investigated the inhibitory activity of several
1,3,4-thiadiazole-sulfonamides against all catalytically active CA (EC 4.2.1.1),
CA I-XV. The tail derivatizing the 5-position in the
1,3,4-thiadiazole-2-sulfonamide scaffold was observed to be critical as an
inhibitory determinant of these compounds. The high resolution X-ray crystal
structure of hCA II in complex with
5-(1-adamantylcarboxamido)-1,3,4-thiadiazole-2-sulfonamide, showed the adamantyl
moiety of the inhibitor residing in a less utilized binding pocket than that of
most hydrophobic inhibitors, lined by the amino acid residues Ile91, Val121 and
Phe131. This binding site may explain the diverse inhibition profiles of
5-carboxamide- and sufonamide-derivatized 1,3,4-thiadiazole-2-sulfonamides and
offers a hot spot for designing isoform selective inhibitors, considering that
residues 91 and 131 are highly variable among the 13 catalytically active
isoforms.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
F.Carta,
V.Garaj,
A.Maresca,
J.Wagner,
B.S.Avvaru,
A.H.Robbins,
A.Scozzafava,
R.McKenna,
and
C.T.Supuran
(2011).
Sulfonamides incorporating 1,3,5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII and XIV over cytosolic isoforms I and II: Solution and X-ray crystallographic studies.
|
| |
Bioorg Med Chem,
19,
3105-3119.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
F.Mincione,
F.Benedini,
S.Biondi,
A.Cecchi,
C.Temperini,
G.Formicola,
I.Pacileo,
A.Scozzafava,
E.Masini,
and
C.T.Supuran
(2011).
Synthesis and crystallographic analysis of new sulfonamides incorporating NO-donating moieties with potent antiglaucoma action.
|
| |
Bioorg Med Chem Lett,
21,
3216-3221.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.Liu,
D.Obando,
V.Liao,
T.Lifa,
and
R.Codd
(2011).
The many faces of the adamantyl group in drug design.
|
| |
Eur J Med Chem,
46,
1949-1963.
|
 |
|
|
|
|
 |
F.Pacchiano,
M.Aggarwal,
B.S.Avvaru,
A.H.Robbins,
A.Scozzafava,
R.McKenna,
and
C.T.Supuran
(2010).
Selective hydrophobic pocket binding observed within the carbonic anhydrase II active site accommodate different 4-substituted-ureido-benzenesulfonamides and correlate to inhibitor potency.
|
| |
Chem Commun (Camb),
46,
8371-8373.
|
 |
|
PDB codes:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |